Ratnakar Securities Pvt. Ltd.

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories

BSE1434.45-24.85 (-1.7 %)

PREV CLOSE ( ) 1459.30

OPEN PRICE ( ) 1458.55

BID PRICE (QTY) 1432.70 (1)

OFFER PRICE (QTY) 1434.50 (4)

VOLUME 947

TODAY'S LOW / HIGH ( )1432.00 1458.55

52 WK LOW / HIGH ( )1200 1757.65

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-10 1949

Management Info

Premchand Godha - Chairman Pranay Godha - Managing Director

Registered Office

Address 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone 022- 66474444 / 62106050

Email ipca@ipca.com

Website www.ipca.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

05Dec USFDA conducts inspection at Ipca Labo
The United States Food and Drug Administration (USFDA) has conducted the..

12Nov Ipca Laboratories informs about confer
Further to intimation dated 6th November, 2025 and in accordance with Re..

17Oct Ipca Laboratories submits board meetin
Ipca Laboratories has informed that pursuant to Regulation 29 read with..

16Oct Ipca Laboratories informs about incorp
Ipca Laboratories has informed that the Company has incorporated a wholl..

16Oct Ipca Laboratories incorporates subsidi
Ipca Laboratories has incorporated a wholly owned subsidiary by the name..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	3047.4	6507.6
Gross Profit	4083.1	9997.7
Operating Profit	4866.3	15963.2
Net Sales	19303.2	66779.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE) 4839.95 (4.06%)	M.Cap ( in Cr)10711.54
Albert David (BSE) 790.00 (2.96%)	M.Cap ( in Cr)437.91
Trident Lifeline (BSE) 320.00 (5.54%)	M.Cap ( in Cr)354.68
Ajanta Pharma (BSE) 2650.35 (0.44%)	M.Cap ( in Cr)32967.39
Samrat Pharmachem (BSE) 259.00 (2.25%)	M.Cap ( in Cr)78.26

Shareholding Pattern

	NON-INSTITUTION	8.08%
	FI/BANKS/INSURANCE	5.99%
	PROMOTERS	44.72%
	MUTUAL FUNDS/UTI	30.04%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	7.39
HDFC Pharma and Hea...	4.50
DSP Focused Fund-Reg(G)	3.87
Tata Nifty MidSmall...	3.55
Aditya Birla SL Pha...	3.55
Motilal Oswal Nifty...	3.53

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

IPCA LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES